Obsessive-Compulsive Disorder (OCD) is a significant mental health condition characterized by obsessions and compulsions that substantially impair daily functioning. Affecting 1% to 3% of the global population, OCD presents a complex clinical picture that often overlaps with other psychiatric disorders. Accurate diagnosis is paramount for effective treatment, making Ocd Differential Diagnosis a critical skill for healthcare professionals. This article provides an in-depth exploration of the differential diagnosis of OCD, equipping clinicians with the knowledge to distinguish it from conditions with similar symptom profiles and ensure optimal patient care. Understanding the nuances of OCD and its overlapping symptoms with other disorders is crucial for avoiding misdiagnosis and implementing targeted, evidence-based interventions. This comprehensive guide will delve into the key differentiating features of OCD from other psychiatric conditions, enhancing diagnostic accuracy and improving outcomes for individuals struggling with obsessive-compulsive symptoms.
Etiology of OCD: Understanding the Complexity
The etiology of OCD is multifaceted, involving a complex interplay of genetic, neurobiological, cognitive, and environmental factors. Twin studies suggest a significant genetic component, with heritability estimates around 48%. While specific genes remain elusive, research points to neurotransmitter systems, particularly serotonin, dopamine, and glutamate, as playing crucial roles. The cortico-striato-thalamo-cortical (CSTC) loop is central to the pathophysiology of OCD. Imbalances within this network, particularly hyperactivity in the direct pathway, are believed to contribute to the repetitive thoughts and compulsive behaviors characteristic of the disorder. Neuroimaging studies consistently show altered connectivity and activation within the CSTC loop in individuals with OCD.
Furthermore, autoimmune processes, especially in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) and Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), are increasingly recognized as potential contributors, particularly in childhood-onset OCD. Cognitive and learning-based models highlight the role of maladaptive beliefs, such as inflated responsibility and intolerance of uncertainty, in fueling obsessional anxiety and compulsive behaviors. These models emphasize that compulsions are learned responses aimed at reducing the distress caused by obsessions. Understanding this complex etiology is essential for appreciating the heterogeneous nature of OCD and the challenges in its differential diagnosis.
Epidemiology and Clinical Presentation of OCD
OCD is a global health concern, with a lifetime prevalence estimated between 1% and 3%. It typically manifests early in life, with a peak onset between ages 18 and 29. Interestingly, males often show symptoms earlier than females, with nearly a quarter experiencing onset before age 10. Women are approximately 1.6 times more likely to be diagnosed with OCD. Comorbidity is highly prevalent in OCD, with about 90% of individuals meeting criteria for at least one other psychiatric disorder, most commonly anxiety disorders, mood disorders, and impulse-control disorders. Despite its prevalence and impact, OCD often remains underdiagnosed and undertreated.
Clinically, OCD is characterized by obsessions, compulsions, or both. Obsessions are intrusive, unwanted, and distressing thoughts, urges, or mental images that the individual attempts to suppress or neutralize. Compulsions are repetitive behaviors or mental acts that individuals feel driven to perform in response to an obsession, aimed at reducing anxiety or preventing a dreaded event. Common obsessions include contamination fears, fears of harm, forbidden thoughts (aggressive, sexual, religious), and symmetry obsessions. Associated compulsions range from excessive cleaning and checking to mental rituals, ordering, and counting. Recognizing these diverse presentations is crucial when considering ocd differential diagnosis as symptoms can mimic those of other conditions.
Pathophysiology and Diagnostic Criteria
The pathophysiology of OCD is increasingly understood through the lens of neural circuitry and neurotransmitter imbalances, particularly within the basal ganglia and the CSTC loop. While structural brain differences are not consistently observed across all OCD patients, functional neuroimaging studies reveal altered activity in the orbitofrontal cortex, anterior cingulate cortex, and striatum. Postmortem studies suggest potential abnormalities in synaptic gene expression within the orbitofrontal cortex.
Diagnosis of OCD relies on the criteria outlined in the DSM-5-TR. These criteria stipulate that either obsessions or compulsions must be present, they must be time-consuming (taking more than one hour per day) or cause significant distress or impairment in social, occupational, or other important areas of functioning. Furthermore, the symptoms must not be attributable to the physiological effects of a substance or another medical condition, and they must not be better explained by the symptoms of another mental disorder. This last point underscores the importance of ocd differential diagnosis. Clinical assessment, including a thorough history and mental status examination, is essential to determine if these criteria are met and to differentiate OCD from other conditions.
History, Physical Examination, and Evaluation in OCD Diagnosis
A comprehensive clinical assessment is the cornerstone of OCD diagnosis. This involves a detailed history, including the nature, onset, severity, and impact of obsessions and compulsions. Clinicians should inquire about specific symptom dimensions, such as contamination, harm, forbidden thoughts, and symmetry. It’s also crucial to assess for comorbid psychiatric conditions, past psychiatric and medical history, current medications, and psychosocial background. In sensitive cases, such as postpartum OCD, clinicians need to create a confidential and nonjudgmental environment to facilitate disclosure of distressing thoughts.
The mental status examination (MSE) can reveal key features of OCD. Patients may exhibit visible anxiety, psychomotor agitation (e.g., repetitive behaviors), and speech patterns disrupted by intrusive thoughts. Mood and affect often reflect anxiety and distress. Thought content will reveal the nature of obsessions, while thought process may be intermittently interrupted by these intrusive thoughts. Insight is typically preserved, with patients recognizing the irrationality of their symptoms, although judgment may be impaired in resisting compulsions.
Evaluation tools, such as the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), are widely used to assess the severity of OCD symptoms. The Y-BOCS rates the severity of obsessions and compulsions across several dimensions, providing a quantitative measure of symptom burden. Screening tools like the short OCD screener can also be helpful in initial identification of potential OCD cases. These evaluations, combined with clinical judgment, are vital for accurate diagnosis and for guiding the process of ocd differential diagnosis.
OCD Differential Diagnosis: Distinguishing OCD from Similar Conditions
The differential diagnosis of OCD is extensive due to the symptom overlap with numerous other psychiatric conditions. It is crucial to systematically differentiate OCD from these conditions to ensure accurate diagnosis and appropriate treatment. Below is a detailed comparison of OCD with common differential diagnoses:
1. Generalized Anxiety Disorder (GAD) vs. OCD
While both GAD and OCD involve anxiety, the focus and nature of the anxiety differ significantly. In GAD, anxiety is excessive and pervasive, related to real-life worries about various events or activities. The worry is often realistic in proportion to the situation, although excessive. In contrast, OCD obsessions are intrusive, irrational, and often ego-dystonic thoughts, urges, or images. They are not simply excessive worries about real-life problems. Furthermore, compulsions are a defining feature of OCD and are absent in GAD. Individuals with OCD perform compulsions to reduce anxiety triggered by obsessions, whereas individuals with GAD do not engage in ritualistic behaviors to alleviate their general worries. The content of worries in GAD is also typically more grounded in reality compared to the often bizarre or improbable nature of OCD obsessions.
2. Specific Phobia vs. OCD
Specific phobias involve intense fear or anxiety triggered by specific objects or situations (e.g., spiders, heights). While avoidance is common in both phobias and OCD, the underlying mechanisms and symptom profiles differ. In specific phobias, the fear is circumscribed to a particular phobic stimulus, and avoidance behaviors are aimed at escaping or avoiding the feared object or situation. There are no obsessions or compulsions in the OCD sense. In OCD, while obsessions can be focused on feared outcomes (e.g., contamination leading to illness), the disorder is characterized by both intrusive thoughts and repetitive behaviors aimed at neutralizing these thoughts or preventing feared outcomes. The anxiety in phobias is directly related to the phobic stimulus, whereas in OCD, anxiety is driven by obsessions, which then lead to compulsions. Rituals and compulsions are not features of specific phobias.
3. Social Anxiety Disorder (Social Phobia) vs. OCD
Social anxiety disorder involves marked fear or anxiety about social situations in which the individual may be scrutinized by others. While avoidance behaviors are present in both conditions, the motivation and nature of avoidance differ. In social anxiety, avoidance is aimed at preventing social humiliation or negative evaluation. The fear is centered on social performance and interactions. In OCD, avoidance may occur, but it is typically related to obsession triggers (e.g., avoiding public restrooms due to contamination fears). Furthermore, OCD is defined by obsessions and compulsions, which are not core features of social anxiety disorder. While individuals with social anxiety may engage in safety behaviors to reduce social anxiety, these are not compulsions in the OCD sense. The focus of fear in social anxiety is social situations, while in OCD, obsessions can be varied and not necessarily related to social contexts.
4. Major Depressive Disorder (MDD) vs. OCD
MDD and OCD can co-occur, and differentiating them is crucial. MDD is characterized by persistent sadness, loss of interest, and other depressive symptoms. Ruminative thoughts are common in depression, but these are typically mood-congruent (e.g., thoughts of worthlessness, guilt). In OCD, obsessions are intrusive and unwanted thoughts, images, or urges that are not necessarily mood-congruent and are often resisted. Compulsions, the hallmark of OCD, are absent in MDD. While depressive symptoms can occur in OCD as a consequence of the distress and impairment caused by obsessions and compulsions, the primary features of MDD are mood-related, whereas OCD is primarily characterized by obsessions and compulsions. Distinguishing between primary depression with secondary obsessions and compulsions versus primary OCD with secondary depression is essential for treatment planning.
5. Body Dysmorphic Disorder (BDD) vs. OCD
BDD is now classified within the obsessive-compulsive and related disorders in DSM-5-TR, reflecting its close relationship to OCD. BDD is characterized by preoccupation with perceived defects or flaws in physical appearance that are not observable or appear slight to others. Individuals with BDD engage in repetitive behaviors (e.g., mirror checking, excessive grooming) or mental acts (e.g., comparing appearance to others) in response to appearance concerns. While these repetitive behaviors resemble compulsions, they are exclusively focused on appearance. In OCD, obsessions and compulsions can be broader and not solely related to appearance. If the preoccupations and repetitive behaviors are limited to appearance concerns, BDD is the more appropriate diagnosis. If the obsessions and compulsions extend beyond appearance, a diagnosis of OCD should be considered, potentially with comorbid BDD if appearance concerns are also present.
6. Trichotillomania (Hair-Pulling Disorder) and Excoriation (Skin-Picking) Disorder vs. OCD
Trichotillomania and excoriation disorder are also classified as obsessive-compulsive and related disorders. Trichotillomania involves recurrent pulling out of one’s hair, resulting in hair loss, despite repeated attempts to decrease or stop. Excoriation disorder involves recurrent skin picking, resulting in skin lesions, despite repeated attempts to decrease or stop. These conditions involve compulsive behaviors, but typically lack the obsessions that drive compulsions in OCD. The repetitive behaviors in trichotillomania and excoriation disorder are primarily focused on hair pulling and skin picking, respectively, and are not performed in response to intrusive obsessions. If hair pulling or skin picking occurs in response to obsessions (e.g., fear of contamination leading to skin picking), then a diagnosis of OCD may be more appropriate, or these conditions may be considered comorbid with OCD.
7. Hoarding Disorder vs. OCD
Hoarding disorder, also within the obsessive-compulsive and related disorders, is characterized by persistent difficulty discarding possessions, regardless of their actual value, due to a perceived need to save the items and distress associated with discarding them. Hoarding can occur in OCD, but hoarding disorder is distinct. In hoarding disorder, the primary issue is the accumulation and inability to discard possessions. If hoarding behavior is driven by OCD-like obsessions (e.g., fear of harm if items are discarded), an OCD diagnosis may be given. However, if the hoarding is not primarily driven by obsessions but by the difficulty discarding and perceived need to save, hoarding disorder is the principal diagnosis. Careful assessment of the motivation behind hoarding behavior is crucial for ocd differential diagnosis.
8. Eating Disorders vs. OCD
Eating disorders, such as anorexia nervosa and bulimia nervosa, involve disturbances in eating behavior and body image. Ritualized eating behaviors and preoccupation with weight and food can sometimes resemble compulsions and obsessions. However, in eating disorders, the focus of obsessions and compulsions is specifically related to weight, body shape, and food intake. In OCD, obsessions and compulsions are broader and not solely focused on eating or body image. If ritualized behaviors are primarily related to eating and weight control, an eating disorder diagnosis is more appropriate. If obsessions and compulsions extend beyond eating and body image, OCD should be considered, possibly with comorbid eating disorder if eating-related symptoms are also present.
9. Tic Disorders and Tourette Syndrome vs. OCD
Tic disorders, including Tourette syndrome, involve sudden, rapid, recurrent, nonrhythmic motor movements or vocalizations (tics). Tics can be complex and may sometimes resemble compulsions. However, tics are typically involuntary and not performed in response to obsessions. Compulsions in OCD are driven by obsessions and are performed to reduce anxiety or prevent a feared outcome. While tics can be temporarily suppressed, compulsions are often felt as driven and necessary. OCD and tic disorders can co-occur; in such cases, a dual diagnosis is warranted. Careful differentiation involves assessing the intentionality and motivation behind the repetitive behaviors. If behaviors are preceded by obsessions and aimed at anxiety reduction, OCD is more likely. If behaviors are involuntary and tic-like, a tic disorder should be considered.
10. Psychotic Disorders vs. OCD
Psychotic disorders, such as schizophrenia, are characterized by hallucinations, delusions, disorganized thinking, and negative symptoms. While some OCD patients may have poor insight or even overvalued ideation, they typically do not exhibit true delusions or hallucinations. Obsessions are ego-dystonic and recognized as intrusive and unwanted, even if the individual struggles to resist them. In psychotic disorders, delusions are fixed false beliefs that are held with conviction and are not recognized as irrational by the individual. Hallucinations are sensory perceptions in the absence of external stimuli. While rare, some individuals with severe OCD may have poor insight and delusional beliefs related to their obsessions. Distinguishing between poor insight OCD and psychotic disorders relies on assessing the nature of the beliefs and the presence of other psychotic symptoms like hallucinations and disorganized thinking. In cases of diagnostic uncertainty, longitudinal assessment and response to OCD-specific treatments can aid in ocd differential diagnosis.
11. Obsessive-Compulsive Personality Disorder (OCPD) vs. OCD
OCPD and OCD are distinct disorders, although they share the term “obsessive-compulsive.” OCPD is a personality disorder characterized by a pervasive pattern of preoccupation with orderliness, perfectionism, and control, at the expense of flexibility, openness, and efficiency. Individuals with OCPD are rigid, perfectionistic, and focused on rules, lists, order, and organization. Critically, OCPD does not involve true obsessions and compulsions in the way OCD does. The traits in OCPD are ego-syntonic, meaning they are consistent with the individual’s self-image and are often seen as rational and desirable. In contrast, OCD obsessions and compulsions are ego-dystonic, distressing, and recognized as excessive or irrational (at least at some point in the disorder’s course). While both conditions involve rigidity and control, OCD is marked by intrusive, distressing obsessions and anxiety-driven compulsions, which are absent in OCPD. Individuals with OCPD may value order and control, but they do not experience the distressing, intrusive thoughts and the compulsion to perform rituals to alleviate anxiety that are characteristic of OCD.
12. Adjustment Disorder with Anxiety vs. OCD
Adjustment disorder with anxiety is diagnosed when anxiety symptoms develop in response to an identifiable stressor and cause clinically significant distress or impairment. While OCD symptoms can be exacerbated by stress, OCD is not caused by a specific stressor and is a distinct clinical entity. If obsessive-compulsive symptoms arise only in the context of a stressor and remit once the stressor is removed, an adjustment disorder with anxiety might be considered. However, if the symptoms meet full criteria for OCD (obsessions, compulsions, time-consuming, distressing, impairing) and persist beyond the expected resolution of a stressor, OCD is the more appropriate diagnosis. Careful history taking to assess the onset and course of symptoms in relation to stressors is important for ocd differential diagnosis.
Prognosis and Complications of Untreated OCD
OCD is typically a chronic condition with fluctuating symptom severity. Without treatment, OCD can significantly impair daily functioning, social interactions, and overall quality of life. Untreated OCD is associated with an increased risk of comorbid psychiatric disorders, including depression and anxiety disorders, and a heightened risk of suicidal ideation and attempts. The longer OCD goes untreated, the more entrenched the patterns of obsessions and compulsions become, potentially leading to structural changes in the brain and making treatment more challenging. Early intervention is crucial to improve prognosis and prevent long-term complications.
Complications of untreated OCD include social isolation, occupational difficulties, relationship problems, physical health issues (e.g., dermatitis from excessive washing), and significant psychological distress. OCD is recognized by the WHO as one of the top 10 disabling conditions. Recognizing the potential for chronic impairment and serious complications underscores the importance of accurate ocd differential diagnosis and timely, effective treatment.
Consultations and Enhancing Healthcare Team Outcomes
Effective management of OCD often requires a multidisciplinary approach. Consultation with mental health specialists, particularly therapists trained in Cognitive Behavioral Therapy (CBT) with Exposure and Response Prevention (ERP), is essential for non-pharmacological treatment. Medical consultations may be necessary for managing comorbid conditions or physical complications arising from compulsions (e.g., dermatological consultations for excessive washing).
An interprofessional healthcare team approach is vital for optimizing outcomes in OCD. This team may include primary care physicians, psychiatrists, clinical psychologists, occupational therapists, pharmacists, and social workers. Effective communication and collaboration among team members ensure comprehensive, patient-centered care. Primary care physicians often serve as the first point of contact and play a crucial role in initial identification and referral. Psychiatrists manage diagnosis and pharmacotherapy. Clinical psychologists provide psychological assessments and CBT/ERP. Occupational therapists address functional impairments, and social workers facilitate access to community resources. Pharmacists ensure medication management and adherence. This collaborative approach, emphasizing shared decision-making and ongoing professional development, is crucial for enhancing healthcare team outcomes and improving the lives of individuals with OCD.
Conclusion: The Importance of Accurate OCD Differential Diagnosis
Accurate ocd differential diagnosis is fundamental to providing effective care for individuals with obsessive-compulsive symptoms. OCD shares symptom overlap with a wide range of psychiatric conditions, necessitating careful clinical assessment to differentiate it from GAD, phobias, social anxiety disorder, MDD, BDD, tic disorders, psychotic disorders, OCPD, and others. Understanding the unique features of OCD, including the presence of ego-dystonic obsessions and anxiety-driven compulsions, as well as utilizing structured diagnostic criteria and assessment tools, are key to improving diagnostic accuracy. By mastering the nuances of ocd differential diagnosis, healthcare professionals can ensure that individuals with OCD receive timely, targeted, and evidence-based interventions, leading to better outcomes and improved quality of life. Continued education and vigilance in recognizing and differentiating OCD are essential for all clinicians involved in mental healthcare.
References
1.Zai G, Barta C, Cath D, Eapen V, Geller D, Grünblatt E. New insights and perspectives on the genetics of obsessive-compulsive disorder. Psychiatr Genet. 2019 Oct;29(5):142-151. [PubMed: 31464995]
2.Strom NI, Soda T, Mathews CA, Davis LK. A dimensional perspective on the genetics of obsessive-compulsive disorder. Transl Psychiatry. 2021 Jul 21;11(1):401. [PMC free article: PMC8295308] [PubMed: 34290223]
3.Stein DJ, Costa DLC, Lochner C, Miguel EC, Reddy YCJ, Shavitt RG, van den Heuvel OA, Simpson HB. Obsessive-compulsive disorder. Nat Rev Dis Primers. 2019 Aug 01;5(1):52. [PMC free article: PMC7370844] [PubMed: 31371720]
4.Blanco-Vieira T, Radua J, Marcelino L, Bloch M, Mataix-Cols D, do Rosário MC. The genetic epidemiology of obsessive-compulsive disorder: a systematic review and meta-analysis. Transl Psychiatry. 2023 Jun 28;13(1):230. [PMC free article: PMC10307810] [PubMed: 37380645]
5.Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry. 2005 Feb;162(2):228-38. [PubMed: 15677583]
6.Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry. 2008 Dec;165(12):1532-42. [PMC free article: PMC3972003] [PubMed: 18923068]
7.Taylor S, McKay D, Miguel EC, De Mathis MA, Andrade C, Ahuja N, Sookman D, Kwon JS, Huh MJ, Riemann BC, Cottraux J, O’Connor K, Hale LR, Abramowitz JS, Fontenelle LF, Storch EA. Musical obsessions: a comprehensive review of neglected clinical phenomena. J Anxiety Disord. 2014 Aug;28(6):580-9. [PubMed: 24997394]
8.Greenberg D, Huppert JD. Scrupulosity: a unique subtype of obsessive-compulsive disorder. Curr Psychiatry Rep. 2010 Aug;12(4):282-9. [PubMed: 20544313]
9.Fornaro M, Gabrielli F, Albano C, Fornaro S, Rizzato S, Mattei C, Solano P, Vinciguerra V, Fornaro P. Obsessive-compulsive disorder and related disorders: a comprehensive survey. Ann Gen Psychiatry. 2009 May 18;8:13. [PMC free article: PMC2686696] [PubMed: 19450269]
10.Hollander E, Braun A, Simeon D. Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Depress Anxiety. 2008;25(4):317-29. [PubMed: 18412058]
11.Veale D, Roberts A. Obsessive-compulsive disorder. BMJ. 2014 Apr 07;348:g2183. [PubMed: 24709802]
12.Fernandez TV, Leckman JF, Pittenger C. Genetic susceptibility in obsessive-compulsive disorder. Handb Clin Neurol. 2018;148:767-781. [PubMed: 29478613]
13.Goodman WK, Storch EA, Sheth SA. Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder. Am J Psychiatry. 2021 Jan 01;178(1):17-29. [PMC free article: PMC8091795] [PubMed: 33384007]
14.Mahjani B, Klei L, Hultman CM, Larsson H, Devlin B, Buxbaum JD, Sandin S, Grice DE. Maternal Effects as Causes of Risk for Obsessive-Compulsive Disorder. Biol Psychiatry. 2020 Jun 15;87(12):1045-1051. [PMC free article: PMC8023336] [PubMed: 32199606]
15.Escobar AP, Wendland JR, Chávez AE, Moya PR. The Neuronal Glutamate Transporter EAAT3 in Obsessive-Compulsive Disorder. Front Pharmacol. 2019;10:1362. [PMC free article: PMC6872633] [PubMed: 31803055]
16.Yuste R. From the neuron doctrine to neural networks. Nat Rev Neurosci. 2015 Aug;16(8):487-97. [PubMed: 26152865]
17.Maraone A, Tarsitani L, Pinucci I, Pasquini M. Antiglutamatergic agents for obsessive-compulsive disorder: Where are we now and what are possible future prospects? World J Psychiatry. 2021 Sep 19;11(9):568-580. [PMC free article: PMC8474998] [PubMed: 34631461]
18.Shitova AD, Zharikova TS, Kovaleva ON, Luchina AM, Aktemirov AS, Olsufieva AV, Sinelnikov MY, Pontes-Silva A, Zharikov YO. Tourette syndrome and obsessive-compulsive disorder: A comprehensive review of structural alterations and neurological mechanisms. Behav Brain Res. 2023 Sep 13;453:114606. [PubMed: 37524204]
19.Bird JS, Shah E, Shotbolt P. Epilepsy and concomitant obsessive-compulsive disorder. Epilepsy Behav Case Rep. 2018;10:106-110. [PMC free article: PMC6158956] [PubMed: 30271707]
20.Parmar A, Verma R. A Case of Obsessive-Compulsive Disorder Comorbid with Miyoshi Myopathy. Indian J Psychol Med. 2018 Jan-Feb;40(1):86-88. [PMC free article: PMC5795685] [PubMed: 29403136]
21.Simpson HB, Slifstein M, Bender J, Xu X, Hackett E, Maher MJ, Abi-Dargham A. Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907. Biol Psychiatry. 2011 Nov 01;70(9):897-904. [PMC free article: PMC3951757] [PubMed: 21855857]
22.Pallanti S, Bernardi S, Antonini S, Singh N, Hollander E. Ondansetron augmentation in patients with obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: improvement with treatment and worsening following discontinuation. Eur Neuropsychopharmacol. 2014 Mar;24(3):375-80. [PubMed: 24406025]
23.Sakurai H, Dording C, Yeung A, Foster S, Jain F, Chang T, Trinh NH, Bernard R, Boyden S, Iqbal SZ, Wilkinson ST, Mathew SJ, Mischoulon D, Fava M, Cusin C. Longer-term open-label study of adjunctive riluzole in treatment-resistant depression. J Affect Disord. 2019 Nov 01;258:102-108. [PMC free article: PMC6710149] [PubMed: 31400624]
24.Grassi G, Cecchelli C, Vignozzi L, Pacini S. Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder. J Exp Pharmacol. 2020;12:695-706. [PMC free article: PMC7801912] [PubMed: 33447096]
25.Jalal B, Chamberlain SR, Sahakian BJ. Obsessive-compulsive disorder: Etiology, neuropathology, and cognitive dysfunction. Brain Behav. 2023 Jun;13(6):e3000. [PMC free article: PMC10275553] [PubMed: 37137502]
26.Grant JE, Hook R, Valle S, Chesivoir E, Chamberlain SR. Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial. Int Clin Psychopharmacol. 2021 Sep 01;36(5):225-229. [PMC free article: PMC7611531] [PubMed: 34310432]
27.Murphy TK, Patel PD, McGuire JF, Kennel A, Mutch PJ, Parker-Athill EC, Hanks CE, Lewin AB, Storch EA, Toufexis MD, Dadlani GH, Rodriguez CA. Characterization of the pediatric acute-onset neuropsychiatric syndrome phenotype. J Child Adolesc Psychopharmacol. 2015 Feb;25(1):14-25. [PMC free article: PMC4340632] [PubMed: 25314221]
28.Xu J, Liu RJ, Fahey S, Frick L, Leckman J, Vaccarino F, Duman RS, Williams K, Swedo S, Pittenger C. Antibodies From Children With PANDAS Bind Specifically to Striatal Cholinergic Interneurons and Alter Their Activity. Am J Psychiatry. 2021 Jan 01;178(1):48-64. [PMC free article: PMC8573771] [PubMed: 32539528]
29.Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry. 2006 Jun;51(7):407-16. [PubMed: 16838822]
30.Baxter AJ, Vos T, Scott KM, Ferrari AJ, Whiteford HA. The global burden of anxiety disorders in 2010. Psychol Med. 2014 Aug;44(11):2363-74. [PubMed: 24451993]
31.Fairbrother N, Collardeau F, Albert AYK, Challacombe FL, Thordarson DS, Woody SR, Janssen PA. High Prevalence and Incidence of Obsessive-Compulsive Disorder Among Women Across Pregnancy and the Postpartum. J Clin Psychiatry. 2021 Mar 23;82(2) [PubMed: 34033273]
32.Fawcett EJ, Power H, Fawcett JM. Women Are at Greater Risk of OCD Than Men: A Meta-Analytic Review of OCD Prevalence Worldwide. J Clin Psychiatry. 2020 Jun 23;81(4) [PubMed: 32603559]
33.Senter MS, Patel SR, Dixon LB, Myers RW, Simpson HB. Defining and Addressing Gaps in Care for Obsessive-Compulsive Disorder in the United States. Psychiatr Serv. 2021 Jul 01;72(7):784-793. [PubMed: 33957763]
34.Bruin WB, Taylor L, Thomas RM, Shock JP, Zhutovsky P, Abe Y, Alonso P, Ameis SH, Anticevic A, Arnold PD, Assogna F, Benedetti F, Beucke JC, Boedhoe PSW, Bollettini I, Bose A, Brem S, Brennan BP, Buitelaar JK, Calvo R, Cheng Y, Cho KIK, Dallaspezia S, Denys D, Ely BA, Feusner JD, Fitzgerald KD, Fouche JP, Fridgeirsson EA, Gruner P, Gürsel DA, Hauser TU, Hirano Y, Hoexter MQ, Hu H, Huyser C, Ivanov I, James A, Jaspers-Fayer F, Kathmann N, Kaufmann C, Koch K, Kuno M, Kvale G, Kwon JS, Liu Y, Lochner C, Lázaro L, Marques P, Marsh R, Martínez-Zalacaín I, Mataix-Cols D, Menchón JM, Minuzzi L, Moreira PS, Morer A, Morgado P, Nakagawa A, Nakamae T, Nakao T, Narayanaswamy JC, Nurmi EL, O’Neill J, Pariente JC, Perriello C, Piacentini J, Piras F, Piras F, Reddy YCJ, Rus-Oswald OG, Sakai Y, Sato JR, Schmaal L, Shimizu E, Simpson HB, Soreni N, Soriano-Mas C, Spalletta G, Stern ER, Stevens MC, Stewart SE, Szeszko PR, Tolin DF, Venkatasubramanian G, Wang Z, Yun JY, van Rooij D, ENIGMA-OCD Working Group. Thompson PM, van den Heuvel OA, Stein DJ, van Wingen GA. Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: medication matters. Transl Psychiatry. 2020 Oct 08;10(1):342. [PMC free article: PMC7598942] [PubMed: 33033241]
35.de Oliveira KC, Grinberg LT, Hoexter MQ, Brentani H, Suemoto CK, Nery FG, Lima LC, Alho ATDL, Farfel JM, Ferretti-Rebustini REL, Leite REP, Moretto AC, da Silva AV, Lafer B, Miguel EC, Nitrini R, Jacob-Filho W, Heinsen H, Pasqualucci CA. Layer-specific reduced neuronal density in the orbitofrontal cortex of older adults with obsessive-compulsive disorder. Brain Struct Funct. 2019 Jan;224(1):191-203. [PubMed: 30298291]
36.Krebs G, Heyman I. Obsessive-compulsive disorder in children and adolescents. Arch Dis Child. 2015 May;100(5):495-9. [PMC free article: PMC4413836] [PubMed: 25398447]
37.Heyman I, Mataix-Cols D, Fineberg NA. Obsessive-compulsive disorder. BMJ. 2006 Aug 26;333(7565):424-9. [PMC free article: PMC1553525] [PubMed: 16931840]
38.Schruers K, Baldi S, van den Heuvel T, Goossens L, Luyten L, Leentjens AFG, Ackermans L, Temel Y, Viechtbauer W. The effects of deep-brain non-stimulation in severe obsessive-compulsive disorder: an individual patient data meta-analysis. Transl Psychiatry. 2019 Aug 05;9(1):183. [PMC free article: PMC6683131] [PubMed: 31383848]
39.Öst LG, Havnen A, Hansen B, Kvale G. Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014. Clin Psychol Rev. 2015 Aug;40:156-69. [PubMed: 26117062]
40.Öst LG, Riise EN, Wergeland GJ, Hansen B, Kvale G. Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis. J Anxiety Disord. 2016 Oct;43:58-69. [PubMed: 27632568]
41.Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment. JAMA. 2017 Apr 04;317(13):1358-1367. [PubMed: 28384832]
42.Kvale G, Hansen B, Björgvinsson T, Børtveit T, Hagen K, Haseth S, Kristensen UB, Launes G, Ressler KJ, Solem S, Strand A, van den Heuvel OA, Öst LG. Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-day treatment. BMC Psychiatry. 2018 Oct 04;18(1):323. [PMC free article: PMC6172736] [PubMed: 30286745]
43.Soomro GM, Altman D, Rajagopal S, Oakley-Browne M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD001765. [PMC free article: PMC7025764] [PubMed: 18253995]
44.Bloch MH, McGuire J, Landeros-Weisenberger A, Leckman JF, Pittenger C. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry. 2010 Aug;15(8):850-5. [PMC free article: PMC2888928] [PubMed: 19468281]
45.Stein DJ, Andersen EW, Tonnoir B, Fineberg N. Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study. Curr Med Res Opin. 2007 Apr;23(4):701-11. [PubMed: 17407626]
46.Issari Y, Jakubovski E, Bartley CA, Pittenger C, Bloch MH. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. J Clin Psychiatry. 2016 May;77(5):e605-11. [PubMed: 27249090]
47.Varigonda AL, Jakubovski E, Bloch MH. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder. J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):851-859.e2. [PMC free article: PMC6944467] [PubMed: 27663940]
48.da Conceição Costa DL, Shavitt RG, Castro Cesar RC, Joaquim MA, Borcato S, Valério C, Miguel EC, Diniz JB. Can early improvement be an indicator of treatment response in obsessive-compulsive disorder? Implications for early-treatment decision-making. J Psychiatr Res. 2013 Nov;47(11):1700-7. [PubMed: 23948637]
49.Batelaan NM, Bosman RC, Muntingh A, Scholten WD, Huijbregts KM, van Balkom AJLM. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ. 2017 Sep 13;358:j3927. [PMC free article: PMC5596392] [PubMed: 28903922]
50.Erzegovesi S, Cavallini MC, Cavedini P, Diaferia G, Locatelli M, Bellodi L. Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol. 2001 Oct;21(5):488-92. [PubMed: 11593074]
51.Albert U, Carmassi C, Cosci F, De Cori D, Di Nicola M, Ferrari S, Poloni N, Tarricone I, Fiorillo A. Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, trauma-related, and somatic symptom disorders: a systematized review. Int Clin Psychopharmacol. 2016 Sep;31(5):249-58. [PubMed: 26974213]
52.Dold M, Aigner M, Lanzenberger R, Kasper S. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. Int J Neuropsychopharmacol. 2015 May 04;18(9) [PMC free article: PMC4576518] [PubMed: 25939614]
53.Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CA, Miguel EC. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder. J Clin Psychopharmacol. 2011 Dec;31(6):763-8. [PubMed: 22020357]
54.Costa DLC, Diniz JB, Requena G, Joaquim MA, Pittenger C, Bloch MH, Miguel EC, Shavitt RG. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder. J Clin Psychiatry. 2017 Jul;78(7):e766-e773. [PubMed: 28617566]
55.Dunlop K, Woodside B, Olmsted M, Colton P, Giacobbe P, Downar J. Reductions in Cortico-Striatal Hyperconnectivity Accompany Successful Treatment of Obsessive-Compulsive Disorder with Dorsomedial Prefrontal rTMS. Neuropsychopharmacology. 2016 Apr;41(5):1395-403. [PMC free article: PMC4793124] [PubMed: 26440813]
56.Carmi L, Tendler A, Bystritsky A, Hollander E, Blumberger DM, Daskalakis J, Ward H, Lapidus K, Goodman W, Casuto L, Feifel D, Barnea-Ygael N, Roth Y, Zangen A, Zohar J. Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial. Am J Psychiatry. 2019 Nov 01;176(11):931-938. [PubMed: 31109199]
57.McCathern AG, Mathai DS, Cho RY, Goodman WK, Storch EA. Deep transcranial magnetic stimulation for obsessive compulsive disorder. Expert Rev Neurother. 2020 Oct;20(10):1029-1036. [PubMed: 32684005]
58.Brown LT, Mikell CB, Youngerman BE, Zhang Y, McKhann GM, Sheth SA. Dorsal anterior cingulotomy and anterior capsulotomy for severe, refractory obsessive-compulsive disorder: a systematic review of observational studies. J Neurosurg. 2016 Jan;124(1):77-89. [PubMed: 26252455]
59.Miguel EC, Lopes AC, McLaughlin NCR, Norén G, Gentil AF, Hamani C, Shavitt RG, Batistuzzo MC, Vattimo EFQ, Canteras M, De Salles A, Gorgulho A, Salvajoli JV, Fonoff ET, Paddick I, Hoexter MQ, Lindquist C, Haber SN, Greenberg BD, Sheth SA. Evolution of gamma knife capsulotomy for intractable obsessive-compulsive disorder. Mol Psychiatry. 2019 Feb;24(2):218-240. [PMC free article: PMC6698394] [PubMed: 29743581]
60.Denys D, Graat I, Mocking R, de Koning P, Vulink N, Figee M, Ooms P, Mantione M, van den Munckhof P, Schuurman R. Efficacy of Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Refractory Obsessive-Compulsive Disorder: A Clinical Cohort of 70 Patients. Am J Psychiatry. 2020 Mar 01;177(3):265-271. [PubMed: 31906709]
61.Li N, Baldermann JC, Kibleur A, Treu S, Akram H, Elias GJB, Boutet A, Lozano AM, Al-Fatly B, Strange B, Barcia JA, Zrinzo L, Joyce E, Chabardes S, Visser-Vandewalle V, Polosan M, Kuhn J, Kühn AA, Horn A. A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder. Nat Commun. 2020 Jul 03;11(1):3364. [PMC free article: PMC7335093] [PubMed: 32620886]
62.Tyagi H, Apergis-Schoute AM, Akram H, Foltynie T, Limousin P, Drummond LM, Fineberg NA, Matthews K, Jahanshahi M, Robbins TW, Sahakian BJ, Zrinzo L, Hariz M, Joyce EM. A Randomized Trial Directly Comparing Ventral Capsule and Anteromedial Subthalamic Nucleus Stimulation in Obsessive-Compulsive Disorder: Clinical and Imaging Evidence for Dissociable Effects. Biol Psychiatry. 2019 May 01;85(9):726-734. [PMC free article: PMC6467837] [PubMed: 30853111]
63.Meier SM, Mattheisen M, Mors O, Schendel DE, Mortensen PB, Plessen KJ. Mortality Among Persons With Obsessive-Compulsive Disorder in Denmark. JAMA Psychiatry. 2016 Mar;73(3):268-274. [PMC free article: PMC5082974] [PubMed: 26818216]
64.Torres AR, Prince MJ, Bebbington PE, Bhugra D, Brugha TS, Farrell M, Jenkins R, Lewis G, Meltzer H, Singleton N. Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry. 2006 Nov;163(11):1978-85. [PubMed: 17074950]
65.Bowen R, Rahman H, Dong LY, Khalaj S, Baetz M, Peters E, Balbuena L. Suicidality in People With Obsessive-Compulsive Symptoms or Personality Traits. Front Psychiatry. 2018;9:747. [PMC free article: PMC6339952] [PubMed: 30692943]
66.Nakao T, Okada K, Kanba S. Neurobiological model of obsessive-compulsive disorder: evidence from recent neuropsychological and neuroimaging findings. Psychiatry Clin Neurosci. 2014 Aug;68(8):587-605. [PubMed: 24762196]
67.Fineberg NA, Apergis-Schoute AM, Vaghi MM, Banca P, Gillan CM, Voon V, Chamberlain SR, Cinosi E, Reid J, Shahper S, Bullmore ET, Sahakian BJ, Robbins TW. Mapping Compulsivity in the DSM-5 Obsessive Compulsive and Related Disorders: Cognitive Domains, Neural Circuitry, and Treatment. Int J Neuropsychopharmacol. 2018 Jan 01;21(1):42-58. [PMC free article: PMC5795357] [PubMed: 29036632]
68.Perris F, Cipolla S, Catapano P, Sampogna G, Luciano M, Giallonardo V, Del Vecchio V, Fabrazzo M, Fiorillo A, Catapano F. Duration of Untreated Illness in Patients with Obsessive-Compulsive Disorder and Its Impact on Long-Term Outcome: A Systematic Review. J Pers Med. 2023 Sep 29;13(10) [PMC free article: PMC10608019] [PubMed: 37888064]
69.Van Ameringen M, Patterson B, Simpson W. DSM-5 obsessive-compulsive and related disorders: clinical implications of new criteria. Depress Anxiety. 2014 Jun;31(6):487-93. [PubMed: 24616177]
Disclosure: Hannah Brock declares no relevant financial relationships with ineligible companies.
Disclosure: Abid Rizvi declares no relevant financial relationships with ineligible companies.
Disclosure: Manassa Hany declares no relevant financial relationships with ineligible companies.
